Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T cell Help for B Cell Responses

Fujii, S; Yamasaki, S; Sato, Y; Shimizu, K

Fujii, S (reprint author), RIKEN Ctr Integrat Med Sci IMS, Lab Immunotherapy, Yokohama, Kanagawa, Japan.

FRONTIERS IN IMMUNOLOGY, 2018; 9 ():

Abstract

Vaccines against a variety of infectious diseases have been developed and tested. Although there have been some notable successes, most are less than ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索